ID   MOLM-7
AC   CVCL_7917
SY   MOLM7
DR   cancercelllines; CVCL_7917
DR   Cosmic; 996325
DR   Cosmic; 998757
DR   Cosmic; 999770
DR   Cosmic; 1012094
DR   Cosmic; 1037677
DR   Cosmic; 2089676
DR   Wikidata; Q54906330
RX   PubMed=7873501;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=11734303;
RX   PubMed=14504097;
RX   PubMed=16408098;
RX   PubMed=23955599;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Mutation; HGNC; 2468; SMC3; Simple; p.Arg661Pro (c.1982G>C); ClinVar=VCV001310284; Zygosity=Unspecified (PubMed=23955599).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2122 ! MOLM-6
OI   CVCL_7918 ! MOLM-8
OI   CVCL_7919 ! MOLM-9
OI   CVCL_7920 ! MOLM-10
OI   CVCL_7921 ! MOLM-11
OI   CVCL_L075 ! MOLM-12
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 18
//
RX   PubMed=7873501;
RA   Tsuji-Takayama K., Kamiya T., Nakamura S., Matsuo Y., Adachi T.,
RA   Tsubota T., Imanishi J., Minowada J.;
RT   "Establishment of multiple leukemia cell lines with diverse myeloid
RT   and/or megakaryoblastoid characteristics from a single Ph1 positive
RT   chronic myelogenous leukemia blood sample.";
RL   Hum. Cell 7:167-171(1994).
//
RX   PubMed=10739008; DOI=10.1016/S0145-2126(99)00182-4;
RA   Inoue K., Kohno T., Takakura S., Hayashi Y., Mizoguchi H., Yokota J.;
RT   "Frequent microsatellite instability and BAX mutations in T cell acute
RT   lymphoblastic leukemia cell lines.";
RL   Leuk. Res. 24:255-262(2000).
//
RX   PubMed=11226526; DOI=10.1016/S0145-2126(00)00121-1;
RA   Inoue K., Kohno T., Takakura S., Hayashi Y., Mizoguchi H., Yokota J.;
RT   "Corrigendum to: Frequent microsatellite instability and BAX mutations
RT   in T cell acute lymphoblastic leukemia cell lines Leukemia Research 24
RT   (2000),255-262.";
RL   Leuk. Res. 25:275-278(2001).
//
RX   PubMed=11734303; DOI=10.1016/S0145-2126(01)00097-2;
RA   Hradcova M., Marinov I., Novak J.T., Nemcova J., Stockbauer P.;
RT   "Monoclonal antibody to human chronic myeloid leukemia cell line
RT   MOLM-7 specifically reacts with an antigen of apoptotic cells.";
RL   Leuk. Res. 26:45-54(2002).
//
RX   PubMed=14504097; DOI=10.1182/blood-2003-02-0418;
RA   Taketani T., Taki T., Sugita K., Furuichi Y., Ishii E., Hanada R.,
RA   Tsuchida M., Sugita K., Ida K., Hayashi Y.;
RT   "FLT3 mutations in the activation loop of tyrosine kinase domain are
RT   frequently found in infant ALL with MLL rearrangements and pediatric
RT   ALL with hyperdiploidy.";
RL   Blood 103:1085-1088(2004).
//
RX   PubMed=16408098; DOI=10.1038/sj.leu.2404081;
RA   Quentmeier H., MacLeod R.A.F., Zaborski M., Drexler H.G.;
RT   "JAK2 V617F tyrosine kinase mutation in cell lines derived from
RT   myeloproliferative disorders.";
RL   Leukemia 20:471-476(2006).
//
RX   PubMed=23955599; DOI=10.1038/ng.2731;
RA   Kon A., Shih L.-Y., Minamino M., Sanada M., Shiraishi Y., Nagata Y.,
RA   Yoshida K.-i., Okuno Y., Bando M., Nakato R., Ishikawa S.,
RA   Sato-Otsubo A., Nagae G., Nishimoto A., Haferlach C., Nowak D.,
RA   Sato Y., Alpermann T., Nagasaki M., Shimamura T., Tanaka H., Chiba K.,
RA   Yamamoto R., Yamaguchi T., Otsu M., Obara N., Sakata-Yanagimoto M.,
RA   Nakamaki T., Ishiyama K., Nolte F., Hofmann W.-K., Miyawaki S.,
RA   Chiba S., Mori H., Nakauchi H., Koeffler H.P., Aburatani H.,
RA   Haferlach T., Shirahige K., Miyano S., Ogawa S.;
RT   "Recurrent mutations in multiple components of the cohesin complex in
RT   myeloid neoplasms.";
RL   Nat. Genet. 45:1232-1237(2013).
//